Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
McKesson Corporation
Formerly called
Olcott & McKesson
(1833–1853)
McKesson & Robbins (1853–1999)
McKessonHBOC
(1999–2001)
Type
Public
Traded as NYSE: MCK
S&P 500 Component
Industry Healthcare
Founded New York City, United States
1833; 184 years ago (1833)
Founder John McKesson
Charles Olcott
Headquarters San Francisco, California, U.S.
Key people
John Hammergren
(Chairman and CEO)
Products Pharmaceuticals
Medical technology
Health care services
Revenue IncreaseUS$190.8 billion (2016)
Operating income
IncreaseUS$3.54 billion (2016)
Net income
IncreaseUS$2.25 billion (2016)
Total assets IncreaseUS$56.52 billion (2016)
Total equity IncreaseUS$8.92 billion (2016)
Number of employees
68,000 (2016)
Subsidiaries Rexall Pharmacy Group
Health Mart
Website www.mckesson.com

McKesson Corporation is an American company distributing pharmaceuticals at a retail sale level and providing health information technology, medical supplies, and care management tools. The company had revenues of $198.5 billion in 2017.

McKesson is based in the United States and distributes health care systems, medical supplies and pharmaceutical products. Additionally, McKesson provides extensive network infrastructure for the health care industry; also, it was an early adopter of technologies like bar-code scanning for distribution, pharmacy robotics, and RFID tags.

It is a Fortune Global 500 company, and the 5th highest revenue generating company in the United States.

Founded in New York City as Charles M. Olcott in 1828 and later as Olcott, McKesson & Co. by Charles Olcott and John McKesson in 1833, the business began as an importer and wholesaler of botanical drugs. A third partner, Daniel Robbins joined the enterprise as it grew, and it was renamed McKesson & Robbins following Olcott's death in 1853.

The company successfully emerged from one of the most notorious business/accounting scandals of the 20th century—the McKesson & Robbins scandal, a watershed event that led to major changes in American auditing standards and securities regulations after being exposed in 1938. In the 1960s, McKesson & Robbins merged with Foremost Dairies of San Francisco to form Foremost-McKesson Inc.

Since the mid-20th century, McKesson has derived an increasing proportion of its income from medical technology, rather than pharmaceuticals. This culminated in its purchase of medical information systems firm HBO & Company (HBOC) in 1999; the combined firm was briefly known as McKessonHBOC. Accounting irregularities at HBOC reduced the company's share price by half, and resulted in the dismissal and prosecution of many HBOC executives. The firm's name reverted to "McKesson" in 2001. McKesson Technology Solutions, as the information technology branch of the company is now known, has continued to increase its market share through acquisitions, notably Per Se Technologies, RelayHealth, and Practice Partner.

In 2010, McKesson acquired leading cancer services company US Oncology, Inc. for $2.16 billion, which was integrated into the McKesson Specialty Care Solutions business.

On June 24, 2013, The Wall Street Journal reported that McKesson Chairman and CEO John Hammergren's pension benefits of $159 million had set a record for "the largest pension on file for a current executive of a public company, and almost certainly the largest ever in corporate America." A study in 2012 by GMI Ratings, which tracks executive pay, found that 60% of CEOs at S&P 500 companies have pensions, and their value averages $11.5 million.

In addition to its offices throughout North America, McKesson also has international offices in Australia, Ireland, France, the Netherlands, and the United Kingdom. Today, McKesson is one of the oldest continually operating businesses in the United States.

As of August 23, 2016, McKesson has decided to merge a majority of its IT business with Change Healthcare.

In 2017, McKesson was involved in a number of lawsuits against the state of Arkansas over the supply of vecuronium bromide. McKesson was under contract by Pfizer not to sell to any correctional facility that authorized and carried out Capital punishment.

McKesson Provider Technologies is the retail name for McKesson Technology Solutions; the software development division of McKesson. Their customer base in the United States includes 50% of all health systems, 20% of all physician practices, 25% of home care agencies, and 77% of health systems with more than 200 beds.

On June 20, 2005, McKesson Provider Technologies acquired Medcon, Ltd., an Israeli company which provides Web-based cardiac image and information management solutions for heart centers, that includes: diagnostic digital image management, archiving, procedure reporting, and workflow management.

In October 2013, McKesson agreed to buy a 50% stake in German peer Celesio for $8.3 billion.

Health Mart is a network of over 4,000 independently owned and operated pharmacies. It is a wholly owned subsidiary of McKesson Corporation, which owns the name "Health Mart." McKesson acquired Health Mart owner FoxMeyer in 1996.

In 1991, McKesson Corporation acquired a 100 percent interest in Medis Health and Pharmaceutical Services from Provigo. In 2002, the McKesson Canada name was adopted. McKesson Canada is a wholly owned subsidiary of McKesson Corporation. It includes various business units: McKesson Pharmaceutical, McKesson Automation, McKesson Specialty, McKesson Health Solutions and McKesson Information Solutions.

In March 2016, McKesson agreed to purchase Canadian pharmacy chain Rexall from the Katz Group of Companies for $3 billion. The proposed deal is subject to government approval.

In the United Kingdom, McKesson (operating as McKesson Information Solutions UK Ltd) was a provider of information technology services to the health care industry. In addition to numerous clinical software systems and finance and procurement services, McKesson also was responsible for developing the Electronic Staff Record system for the National Health Service which provided an integrated payroll system for NHS's 1.3 million staff, making it the world’s largest single payroll IT system. McKesson Shared Services also provided payroll services for over 20 NHS Trusts, paying over 100,000 NHS members.

McKesson's United Kingdom base was in Warwick with data centers in Newcastle upon Tyne and Brent Cross and offices in Sheffield, Bangor, Glasgow and Vauxhall, London. Across the United Kingdom, it employed over 500 people.

In June/July 2014 McKesson sold most of their healthcare software business to the private equity firm Symphony Technology Group and indicated also that they would not be re-bidding for the Electronic Staff Record contract. This came after the company had posted significant year on year losses in revenue (16% in the 2012/13 financial year) after taking over a very successful British operation in 2011.

In 2010, McKesson Asia-Pacific was acquired by Medibank Private Ltd.

McKesson ANZ is a fully owned subsidiary of McKesson Corporation. McKesson expanded its footprint in Australia and New Zealand by acquiring Emendo in November, 2012. McKesson ANZ develops and sells healthcare optimization services and software. The company has traditionally been focused on the public markets in Australia and New Zealand. The majority of the District Health Boards in NZ use one or more of McKesson’s Capacity Management solutions.

Christchurch, New Zealand, is one of McKesson’s global Capacity Management R&D centers of excellence. All of McKesson’s R&D for McKesson Capacity Planner is performed in New Zealand. The company employs approximately 40 team members across Australia and New Zealand including general management, R&D, sales, services and support employees.

McKesson Capacity Planner (formerly Emendo CapPlan) is used in more than 40 hospitals in Australia, New Zealand, Britain, Canada and the US to forecast future patient activity and help health systems to allocate resources efficiently and identify unnecessary costs.

In addition to its global headquarters in San Francisco, California, McKesson maintains facilities around North America.

McKesson operated the Mosswood Wine Company from 1978 until 1987, when the division was sold to maintain their focus on pharmaceuticals. The division was founded and run by wine writer Gerald Asher.

Investment goal date:
Dividends reinvested
McKesson Corporation MCK report Q2 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q4 2017
2018-05-11
--
--
Q3 2017
2018-02-07
--
--
Q2 2017
2017-10-26
3.2800
0.0100
Q1 2017
2017-07-27
2.4600
1.4400
Q3 2016
2017-05-18
3.0400
2.8600
Q4 2015
2016-05-04
2.4400
1.9700
Q3 2015
2016-01-27
3.1800
2.7100
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
ALLIANCEBERNSTEIN L.P.
2319256
Ballentine Partners, LLC
5645708
Bank of New York Mellon Corp
2528822
BlackRock Fund Advisors
3085560
BlackRock Inc.
14198977
BlackRock Institutional Trust Company, N.A.
6415891
Capital Research Global Investors
8228633
FMR LLC
3493389
NORTHERN TRUST CORP
2624121
PAR CAPITAL MANAGEMENT INC
2680000
PARNASSUS INVESTMENTS /CA
4280594
STATE STREET CORP
9860926
Vanguard Group, Inc
14028540
Vulcan Value Partners, LLC
3400880
WELLINGTON MANAGEMENT CO LLP
22730846
Major Shareholders
Name Relationship
Total Shares
Holding stocks
HAMMERGREN JOHN H
0.0300% (65000)
MCK /
JULIAN PAUL C
0.0100% (29046)
MCK /
BEER JAMES A
0.0100% (22152)
ALK / MCK / SYMC /
Spratt Randall N
0.0100% (30137)
IMPV / MCK /
% ()